NEW YORK (GenomeWeb News) – Zygem will market Rubicon Genomics' PicoPlex single-cell amplification kits in Australia and New Zealand, under a non-exclusive agreement, Rubicon said today.

Rubicon's kits are used to amplify small clinical samples into large amounts of pure DNA, and they are licensed and sold to clinical markets for pre-implantation and prenatal testing, cancer testing, and for making diagnostics.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.